{"symbol": "ARTL", "name": "Artelo Biosciences", "next_earnings_utc": 1594721100, "next_earnings_period_start_date_utc": 1582934400, "next_earnings_period_end_date_utc": 1590883200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q3", "next_earnings_year": 2020, "next_earnings_quarter": 3, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": 0.0, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": -0.4, "eps_up_revisions": 1, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 0, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "artelobio.com", "year_founded": 2011, "street_address": "888 Prospect Street", "city": "La Jolla", "state": "CA", "zipcode": "92037", "country": "United States", "phone_number": "760-943-1689", "short_description": "Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system and related signaling pathways.", "long_description": "Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system and related signaling pathways. Its product pipeline includes ART27.13, a cannabinoid agonist for the treatment of anorexia associated with cancer; ART12.11, a CBD cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder; and ART26.12, a FABP5 inhibitor for prostate and breast cancer treatment. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is headquartered in La Jolla, California.", "industry_name": "Pharmaceuticals", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 4387070, "total_enterprise": 2404523, "number_of_employees": 1, "outstanding_shares": 3427399, "eps": -1.310139, "diluted_eps": -1.310139, "earnings_from_cont_operations": -3866971, "gross_profit": null, "cash": 1982547, "total_debt": 0, "total_revenue": null, "cash_from_operations": -4104664, "net_income": -3866971, "ebitda": -4601073, "year_low_stock_price": 0.61, "year_high_stock_price": 12.0, "seekingalpha_follower_count": 315, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/ARTL.png"}